Key result
A new flexible ultrasound transducer array provided comparable Doppler signal quality to standard transducers while measuring fetal heart rate at varying locations using only 50% of the transmission power.
Why the study?
Fetal heart rate monitoring with conventional Doppler ultrasound frequently suffers from signal loss due to movement, requiring cumbersome repositioning, while ambulatory use requires reduced acoustic dose and power consumption.
Does a flexible ultrasound transducer array with dynamic power adaptation maintain signal quality and reduce power consumption compared to standard transducers in an in-vitro model?
Does a flexible ultrasound transducer array with dynamic power adaptation maintain signal quality and reduce power consumption compared to standard transducers in an in-vitro model?
A novel flexible ultrasound transducer array with dynamic power adaptation maintains signal quality while reducing transmission power by 50% in an in-vitro model, potentially improving ambulatory fetal heart rate monitoring.
Answers are grounded in this paper and cite their sources.
May reduce signal loss in fetal monitoring; leaves open whether adaptive arrays improve labor outcomes.
Fetal heart rate (fHR) monitoring using Doppler Ultrasound (US) is a standard method to assess fetal health before and during labor. Typically, an US transducer is positioned on the maternal abdomen and directed towards the fetal heart. Due to fetal movement or displacement of the transducer, the relative fetal heart location (fHL) with respect to the US transducer can change, leading to frequent periods of signal loss. Consequently, frequent repositioning of the US transducer is required, which is a cumbersome task affecting clinical workflow. In this research, a new flexible US transducer array is proposed which allows for measuring the fHR independently of the fHL. In addition, a method for dynamic adaptation of the transmission power of this array is introduced with the aim of reducing the total acoustic dose transmitted to the fetus and the associated power consumption, which is an important requirement for application in an ambulatory setting. The method is evaluated using an in-vitro setup of a beating chicken heart. We demonstrate that the signal quality of the Doppler signal acquired with the proposed method is comparable to that of a standard, clinical US transducer. At the same time, our transducer array is able to measure the fHR for varying fHL while only using 50% of the total transmission power of standard, clinical US transducers.
No takes yet. Share an insight, caveat, or question.
Hamelmann et al. (2019) studied Fetal heart rate monitoring. Flexible ultrasound transducer array with dynamic adaptation of transmission power vs. Standard clinical US transducer was evaluated on Signal quality and transmission power. A new flexible ultrasound transducer array provided comparable Doppler signal quality to standard transducers while measuring fetal heart rate at varying locations using only 50% of the transmission power.
Synapse has enriched 10 related papers. Consider them for comparative context: